.Ascendis Pharma has emerged as a possible danger to BioMarin's Voxzogo, reporting phase 3 growth co...
.Though Alkeus Pharmaceuticals' oral eye health condition resource fell short to significantly lesse...
.Along with a triad of biotechs striking the Nasdaq on Friday, it was easy to miss out on a smaller-...
.Invulnerable checkpoint preventions are actually the superheroes of cancer cells treatment. Medicat...
.Invite to today's Chutes & Ladders, our summary of considerable leadership hirings, shootings an...
.Regeneron is back with lasting follow-up for its LAG-3 prevention as well as PD-1 prevention combin...
.AstraZeneca has shared a very early look at the performance of its own in-house antibody-drug conju...
.After revealing a stage 3 launch based on positive midstage results, iTeos and also GSK are lastly ...
.The FDA ought to be actually even more available as well as collaborative to discharge a surge in c...
.It's an abnormally hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX as well as Bicar...